Myomo outlines 10% revenue growth target for 2026 while expanding recurring patient sources and international operations (NYSE:MYO)

Management View - Myomo, Inc. aims for a 10% revenue growth target by 2026, focusing on expanding recurring patient sources and international operations [2] - The company is prioritizing four major objectives: increasing revenue through direct-to-patient marketing, expanding market access via new payer contracts, managing cost structure for operating leverage, and advancing product innovation [2] - CEO Paul Gudonis reported progress in these areas during the Q4 2025 earnings call, emphasizing the importance of these strategies for future growth [2]